Your browser doesn't support javascript.
loading
Clonal expansion of T memory stem cells determines early anti-leukemic responses and long-term CAR T cell persistence in patients.
Biasco, Luca; Izotova, Natalia; Rivat, Christine; Ghorashian, Sara; Richardson, Rachel; Guvenel, Aleks; Hough, Rachael; Wynn, Robert; Popova, Bilyana; Lopes, Andre; Pule, Martin; Thrasher, Adrian J; Amrolia, Persis J.
Afiliação
  • Biasco L; Molecular and Cellular Immunology Section, UCL Great Ormond Street Institute of Child Health, London, UK.
  • Izotova N; Gene Therapy Program, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Harvard Medical School, Boston, MA, USA.
  • Rivat C; Molecular and Cellular Immunology Section, UCL Great Ormond Street Institute of Child Health, London, UK.
  • Ghorashian S; Molecular and Cellular Immunology Section, UCL Great Ormond Street Institute of Child Health, London, UK.
  • Richardson R; Molecular Haematology Section, UCL Great Ormond Street Institute of Child Health, London, UK.
  • Guvenel A; Molecular and Cellular Immunology Section, UCL Great Ormond Street Institute of Child Health, London, UK.
  • Hough R; Molecular and Cellular Immunology Section, UCL Great Ormond Street Institute of Child Health, London, UK.
  • Wynn R; Department of Haematology, University College London Hospital, London, UK.
  • Popova B; Department of Bone Marrow Transplant, Royal Manchester Children's Hospital, Manchester, UK.
  • Lopes A; CRUK UCL Cancer Trials Centre, University College London, London, UK.
  • Pule M; CRUK UCL Cancer Trials Centre, University College London, London, UK.
  • Thrasher AJ; University College London Cancer Institute, London, UK.
  • Amrolia PJ; Molecular and Cellular Immunology Section, UCL Great Ormond Street Institute of Child Health, London, UK.
Nat Cancer ; 2(6): 629-642, 2021 06.
Article em En | MEDLINE | ID: mdl-34345830
ABSTRACT
Low-affinity CD19 chimeric antigen receptor (CAR) T cells display enhanced expansion and persistence, enabling fate tracking through integration site analysis. Here we show that integration sites from early (1 month) and late (>3yr) timepoints cluster separately, suggesting different clonal contribution to early responses and prolonged anti-leukemic surveillance. CAR T central and effector memory cells in patients with long-term persistence remained highly polyclonal, whereas diversity dropped rapidly in patients with limited CAR T persistence. Analysis of shared integrants between the CAR T cell product and post-infusion demonstrated that, despite their low frequency, T memory stem cell clones in the product contributed substantially to the circulating CAR T cell pools, during both early expansion and long-term persistence. Our data may help identify patients at risk of early loss of CAR T cells and highlight the critical role of T memory stem cells both in mediating early anti-leukemic responses and in long-term surveillance by CAR T cells.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Receptores de Antígenos Quiméricos Limite: Humans Idioma: En Revista: Nat Cancer Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Receptores de Antígenos Quiméricos Limite: Humans Idioma: En Revista: Nat Cancer Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Reino Unido